Related Experiment Video
Updated: Aug 10, 2026

Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Childhood encephalopathy: viruses, immune response, and outcome
Michael Clarke1, Richard W Newton, Paul E Klapper
1Department of Paediatric Neurology, Leeds General Infirmary, UK.
Insights
This study reveals that impaired blood-brain barrier function and subsequent antibody production are key in childhood acute encephalopathy. Persistent interferon-alpha indicates a better prognosis for pediatric encephalitis patients.
Area of Science:
- Neurology
- Immunology
- Pediatrics
Background:
- Acute encephalopathy in children presents a diagnostic challenge.
- Understanding the pathogenesis of pediatric encephalitis is crucial for effective treatment.
Purpose of the Study:
- To investigate the roles of viral infection, blood-brain barrier (BBB) function, intrathecal immunoglobulin synthesis, and interferon (IFN) production in childhood acute encephalopathy.
- To correlate the temporal occurrence of these factors with patient outcomes.
Main Methods:
- Prospective study of 22 children with acute encephalopathy.
- Analysis of serum and cerebrospinal fluid (CSF) for viral markers, albumin ratio, immunoglobulin G index, oligoclonal bands, and IFN-alpha.
- Clinical assessment and outcome evaluation up to 3 years post-illness.
Main Results:
- Elevated CSF:serum albumin ratio, indicating BBB disruption, was found in 18/21 children.
- Intrathecal immunoglobulin G synthesis and oligoclonal bands were often preceded or accompanied by BBB impairment.
- Elevated IFN-alpha levels were detected in 16/18 children; its persistence correlated with a good prognosis.
- Poor outcome was associated with younger age, deteriorating EEG, and prolonged BBB impairment.
Conclusions:
- Childhood acute encephalopathy involves initial BBB disruption followed by intrathecal antibody production.
- This study provides in vivo evidence for this pathogenetic mechanism in pediatric encephalitis.
- IFN-alpha persistence is a positive prognostic indicator, while BBB impairment severity and duration are negative indicators.
Abstract:
This study examined children with an acute encephalopathy illness for evidence of viral infection, disordered blood-brain barrier function, intrathecal immunoglobulin synthesis, and interferon (IFN) production, and related their temporal occurrence to outcome. A prospective study of 22 children (13 males, 9 females; age range 1mo to 13y, median 2y 4mo), recorded clinical details, with serum and cerebrospinal fluid (CSF) analysis near presentation and then on convalescent specimens taken up to day 39 of the neurological illness. Outcome was assessed with standard scales between 18 months and 3 years after presentation. A history consistent with viral infection was given in 17 children but laboratory evidence of viral infection was found in only 7 (7/17). In 18 out of 21 children, an elevated CSF:serum albumin ratio indicative of impairment of the blood-CSF and blood-brain barriers was detected at some stage of the illness. In 14 of the 15 children with a raised immunoglobulin G index, and in 12 of the 14 children where the CSF was positive for oligoclonal bands, this was preceded by, or was observed at the same time as, an abnormal albumin ratio. Sixteen children (16/18) had elevated IFN-alpha levels in serum, or CSF, or in both. We conclude that these findings indicate an initial disruption of the blood-brain barrier followed by intrathecal antibody production by activated lymphocytes, clonally restricted to a few antigens. This is the first in vivo study to show this as an important pathogenetic mechanism of encephalitis in children. Poor outcome was associated with young age, a deteriorating electroencephalogram pattern from grade 1 to grade 2, and the degree of blood-brain barrier impairment, particularly when prolonged, but not with Glasgow Coma Scale score. The persistence of IFN-alpha was associated with a good prognosis.
More Related Videos
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
07:36Modeling Encephalopathy of Prematurity Using Prenatal Hypoxia-ischemia with Intra-amniotic Lipopolysaccharide in Rats
Published on: November 20, 2015
Related Concept Videos
Encephalitis ll: Pathophysiology
Encephalitis l: Introduction
Arboviral Encephalitis
Hepatic Encephalopathy
Viral Meningitis
Bacterial Meningitis II: Pathophysiology